Potential therapeutic agents derived from the cannabinoid nucleus.
D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000972:Antineoplastic Agents, Phytogenic; D001067:Appetite Depressants; D002186:Cannabinoids / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use*; D002188:Cannabis / Q000032:analysis; D000242:Cyclic AMP / Q000378:metabolism; D004064:Digestive System / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D005298:Fertility / Q000187:drug effects; D005901:Glaucoma / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D049672:History, 19th Century; D049673:History, 20th Century; D049690:History, Ancient; D006801:Humans; D006993:Hypnotics and Sedatives; D008297:Male; D009292:Narcotic Antagonists; D018377:Neurotransmitter Agents / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D012890:Sleep / Q000187:drug effects; D013329:Structure-Activity Relationship; D014149:Tranquilizing Agents
D000777:Anesthetics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000972:Antineoplastic Agents, Phytogenic; D001067:Appetite Depressants; D002186:Cannabinoids; D006993:Hypnotics and Sedatives; D009292:Narcotic Antagonists; D018377:Neurotransmitter Agents; D011453:Prostaglandins; D014149:Tranquilizing Agents; D000242:Cyclic AMP